JP2009529049A5 - - Google Patents

Download PDF

Info

Publication number
JP2009529049A5
JP2009529049A5 JP2008558346A JP2008558346A JP2009529049A5 JP 2009529049 A5 JP2009529049 A5 JP 2009529049A5 JP 2008558346 A JP2008558346 A JP 2008558346A JP 2008558346 A JP2008558346 A JP 2008558346A JP 2009529049 A5 JP2009529049 A5 JP 2009529049A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
substituted
following structure
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008558346A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009529049A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/005645 external-priority patent/WO2007103347A1/en
Publication of JP2009529049A publication Critical patent/JP2009529049A/ja
Publication of JP2009529049A5 publication Critical patent/JP2009529049A5/ja
Pending legal-status Critical Current

Links

JP2008558346A 2006-03-07 2007-03-05 神経障害の治療のためのメリダマイシン類似体 Pending JP2009529049A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77994006P 2006-03-07 2006-03-07
PCT/US2007/005645 WO2007103347A1 (en) 2006-03-07 2007-03-05 Meridamycin analogues for the treatment of neurodegenerative disorders

Publications (2)

Publication Number Publication Date
JP2009529049A JP2009529049A (ja) 2009-08-13
JP2009529049A5 true JP2009529049A5 (enExample) 2011-04-21

Family

ID=38289934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008558346A Pending JP2009529049A (ja) 2006-03-07 2007-03-05 神経障害の治療のためのメリダマイシン類似体

Country Status (19)

Country Link
US (1) US7745457B2 (enExample)
EP (1) EP1991551A1 (enExample)
JP (1) JP2009529049A (enExample)
KR (1) KR20080099317A (enExample)
CN (1) CN101426796A (enExample)
AR (1) AR059738A1 (enExample)
AU (1) AU2007223962A1 (enExample)
BR (1) BRPI0708611A2 (enExample)
CA (1) CA2643350A1 (enExample)
CR (1) CR10272A (enExample)
EC (1) ECSP088718A (enExample)
IL (1) IL193414A0 (enExample)
MX (1) MX2008011312A (enExample)
NO (1) NO20083695L (enExample)
PE (1) PE20081550A1 (enExample)
RU (1) RU2008132779A (enExample)
TW (1) TW200804400A (enExample)
WO (1) WO2007103347A1 (enExample)
ZA (1) ZA200807678B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1828203A2 (en) * 2004-12-20 2007-09-05 Wyeth Rapamycin derivatives and the uses thereof in the treatment of neurological disorders
RU2394036C2 (ru) * 2004-12-20 2010-07-10 Вайет Аналоги рапамицина и их применение при лечении неврологических, пролиферативных и воспалительных заболеваний

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9302016D0 (en) 1993-02-02 1993-03-17 Sandoz Ltd Compounds
GB9318144D0 (en) 1993-09-01 1993-10-20 Sandoz Ltd Organic compounds
EP0729471A1 (en) 1993-11-19 1996-09-04 Abbott Laboratories Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US20050197356A1 (en) * 2004-03-02 2005-09-08 Wyeth Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents
BRPI0508224A (pt) 2004-03-02 2007-07-17 Wyeth Corp composto ou um sal farmaceuticamente aceitável do mesmo, cepa de actinomiceto, isolado de uma cepa, métodos para a produção de um macrolìdeo e de um composto, produto, composição, métodos de tratamento de um mamìfero e de um distúrbio neurológico, e, uso de um composto
JP2008501342A (ja) 2004-06-03 2008-01-24 ワイス 複合ポリケチドを生成するための生合成遺伝子クラスター
US7595187B2 (en) * 2004-11-12 2009-09-29 Wyeth Elaiophylin biosynthetic gene cluster
EP1828203A2 (en) 2004-12-20 2007-09-05 Wyeth Rapamycin derivatives and the uses thereof in the treatment of neurological disorders
RU2394036C2 (ru) 2004-12-20 2010-07-10 Вайет Аналоги рапамицина и их применение при лечении неврологических, пролиферативных и воспалительных заболеваний

Similar Documents

Publication Publication Date Title
KR101454571B1 (ko) 트레프로스티닐 생산을 위한 중간체 합성
JP6298765B2 (ja) 脳卒中の治療または予防に使用されるするためのフェニルカルバメート化合物
JP2004516278A (ja) 一酸化窒素合成酵素阻害物質であるリン酸塩
JP2021105002A5 (enExample)
JP2007511613A5 (enExample)
JP5838226B2 (ja) フェニルカルバメート誘導体の製造方法
JP2003534312A (ja) 薬剤として有用な環状アミノ酸誘導体
JP6200527B2 (ja) 神経保護用フェニルカルバメート化合物及びこれを含む組成物
KR101673634B1 (ko) 4-옥소-옥타히드로-인돌-1-카르복실산 메틸 에스테르 및 그의 유도체의 제조 방법
JP2015508092A5 (enExample)
JP2005539045A5 (enExample)
JPWO2000048982A1 (ja) (2r)−2−プロピルオクタン酸の製造方法
AU2017376363B2 (en) Class of bifunctional compounds with quaternary ammonium salt structure
JP2023531008A5 (enExample)
DE3780909T2 (de) 7-((meta-substituiert)-phenylglycin)-1-carba-1-dethia-cephalosporine.
HUE034436T2 (en) A method for producing iodinated contrast media
WO2012011128A1 (en) Preparation of prostaglandin derivatives
CN1040440C (zh) 去氢环黄皮酰胺衍生物的制备方法
US8835672B2 (en) Manufacture of a triiodinated contrast agent
AU2003290075B2 (en) Method for production of the r,r (or s,s) configuration of glycopyrronium stereoisomers
CN101939289A (zh) 用于制备伏立诺他的新方法
JP2007526312A5 (enExample)
EP0869952B1 (fr) Derives de 5-naphtalen-1-y1-1,3-dioxanes, leur preparation et leur application en therapeutique
JP3160041B2 (ja) アミン誘導体の製造方法
JP2002528528A (ja) ケチミン類の製造方法